Status:

RECRUITING

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Lead Sponsor:

AbbVie

Conditions:

Hypothyroidism

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

PHASE3

Brief Summary

This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism and are currently stabilized (i.e., in-range thyroid...

Eligibility Criteria

Inclusion

  • Have a diagnosis of primary hypothyroidism made \>= 12 months prior to Screening.
  • Be on continuous thyroid replacement therapy of synthetic T4 for primary hypothyroidism for at least 12 months immediately prior to the Screening Visit.
  • Be on a stable FDA-approved daily dose of synthetic T4 prior to the Screening visit, and must be taking synthetic T4 dose of at least 25 mcg at Screening visit. Must enter the study using the same stable dose to determine dose conversion.
  • Documentation of 1 in-range thyroid-stimulating hormone (TSH) (i.e., within 0.45 - 4.12 mIU/L, inclusive) at Screening and at least 1 additional in range TSH (i.e., within 0.45 - 4.12 mIU/L, inclusive) taken at a minimum of 6 weeks and a maximum of 12 months prior to Screening.

Exclusion

  • Any clinical condition or previous surgery that might affect the absorption, distribution, biotransformation, or excretion of Armour Thyroid or synthetic T4.
  • History of alcohol or other substance abuse within the previous 6 months prior to the Screening.
  • Known or suspected allergy or intolerance to any ingredients of Armour Thyroid, including its excipients, synthetic T4, other thyroid replacement medications, or pork products.

Key Trial Info

Start Date :

April 26 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2028

Estimated Enrollment :

2800 Patients enrolled

Trial Details

Trial ID

NCT06345339

Start Date

April 26 2024

End Date

June 1 2028

Last Update

January 5 2026

Active Locations (139)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 35 (139 locations)

1

Central Research Associates /ID# 255719

Birmingham, Alabama, United States, 35205

2

UAB Hospital /ID# 262565

Birmingham, Alabama, United States, 35233-1932

3

Kaiser San Diego Dept Endocrinology, SCPMG /ID# 262552

Bonita, California, United States, 91902-1230

4

Facey Medical Foundation - Burbank /ID# 262104

Burbank, California, United States, 91505-4554